RankingsPricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. Stockholders' equity

AFC-HD AMS Life Science Co.,Ltd.JP:2927

Market cap
¥12.4B
P/E ratio
8.3x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Aug 31, 202515,200+8.90%
Aug 31, 202413,958+6.09%
Aug 31, 202313,157+5.72%
Aug 31, 202212,445-1.70%
Aug 31, 202112,661+21.00%
Aug 31, 202010,464+3.50%
Aug 31, 201910,110+4.73%
Aug 31, 20189,653+25.96%
Aug 31, 20177,664+3.95%
Aug 31, 20167,373+4.01%
Aug 31, 20157,089+7.89%
Aug 31, 20146,570+3.88%
Aug 31, 20136,324

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)